This site will look much better in a browser that supports web standards, but it is accessible to any browser or Internet device.

Bovine viral diarrhea virus (BVDV) is the most important and economically
devastating viral-based bovine disease in the USA and is the cause of large
economic loss to the cattle industry exceeding $400 million per year. BVDV
infections can take two manifestations, acutely-infected (AI) and
persistently-infected (PI) animals. In its acutely infected form, cows can
show malformed or slow-growing calves, aborted pregnancies, stillborn
fetuses and significant hemorrhagic syndromes. Although serious, AI animals
usually recover and eliminate the virus from their bodies in about two
weeks. The difficulty in managing this disease lies in the fact that some
infected cows and calves are persistently infected and can live for
relatively long periods of time without showing any symptoms. These animals
cannot eliminate the virus from their system and continuously release high
amounts of virus in their bodily secretions and excretions, making them a
continuous source of infection within the herd.
Currently available tests for the detection of animals infected with BVDV
are based on the identification of the viral antigen or nucleic acids in a
blood or tissue sample. Although these tests have merit in identifying PI
animals, they cannot always differentiate between persistent and acute
infections and are unable to identify cows carrying a PI fetus.
Consequently, acutely infected animals are removed resulting in unnecessary
losses, but PI animals remain undetected and continue to spread the virus
causing new infections that perpetuate the infectious cycle. Accurate
identification and elimination of PI animals from an infected herd is the
most cost effective measure to control and eradicate BVDV, underscoring the
criticality of an inexpensive, convenient, and reliable diagnostic test.
Researchers in the University of Wyoming's Departments of Veterinary Science
and Animal Science working on this problem using bovine nucleic acid
arrays, have identified differential gene expression in normal, AI and PI
animals. These genes can be used as diagnostic markers of BVDV infection.
The University of Wyoming Research Products Center has filed a
PCT
application on this procedure and the markers resulting therefrom that might
used to detect the disease. Our researchers have received grants on this
subject for over $400,000 in research funding, so this would be a great
chance for your company to leverage its investment and get involved at an
early stage in this exciting opportunity.
If you would like to learn more about our BVDV work and how your company may
receive research and/or commercial rights to it, please contact the director
of the University of Wyoming Research Products Center,
Davona
Douglass.
Research Products Center
Dept. 3672
1000 E. University Ave.
Laramie, WY 82071
(307)766-2520
Fax: (307) 766-2530
e-mail: WyomingInvents@uwyo.edu